Gender Differences in Quality-of-Life Outcome in Patients Undergoing Endoscopic Endonasal Skull Base Surgery

Abstract

Background Prior studies showed that female patients with chronic rhinosinusitis (CRS) suffer a worse disease-specific quality of life (QoL).

Goal The aim of this study is to investigate gender differences in sinonasal QoL outcomes in patients requiring endoscopic endonasal skull base surgeries (EESBS).

Methods Cross-sectional analysis of patients presenting to our clinic from August 2020 to December 2022 with skull base tumors, spontaneous cerebrospinal fluid (CSF) rhinorrhea, or Grave's orbitopathy (for orbital decompression) was performed. Baseline and postsurgical QoL were measured using the 22-item Sinonasal Outcome Test (SNOT-22). Patients' demographics and comorbidities were reviewed. Patients with concomitant CRS were excluded.

Results Eighty-six patients were included (54 with skull base tumors, 17 Grave's orbitopathy, and 15 spontaneous CSF rhinorrhea). The mean age of the patients was 52 years (range: 12.4–81.5 years), and 51.6% of the patients were females. There was no age difference between female and male patients. Smoking history, asthma, and allergic rhinitis were also similar between the two groups. Female patients had a significantly higher incidence of depression (58.3 vs. 32.4%, p = 0.018) and migraine (50.0 vs. 21.6%, p = 0.007). Female patients had a significantly worse overall SNOT-22 scores at baseline (33.6 vs. 18.2, p = 0.001), at the 3-month follow-up (29.7 vs. 15.5, p = 0.002), and at the 6-month follow-up (33.5 vs. 14.9, p = 0.005). This worse QoL was seen mainly in the ear/facial, sleep, and psychological domains. Linear regression of the SNOT-22 scores and its subdomains adjusting for comorbidities showed that migraine was found to be the most significant determinant of gender differences in the QoL.

Conclusion Female patients who undergo EESBS show higher overall SNOT-22 scores secondary to higher incidence of migraine.

Keywords

patient-reported outcome measures - 22-item Sinonasal Outcome Test - skull base surgery - paranasal sinuses - gender

Publication History

Received: 25 July 2023

Accepted: 20 November 2023

Accepted Manuscript online:
22 November 2023

Article published online:
13 December 2023

• References

• 1 Asokan A, Mace JC, Rice JD, Smith TL, Soler ZM, Ramakrishnan VR. Sex differences in presentation and surgical outcomes from a prospective multicenter chronic rhinosinusitis study. Otolaryngol Head Neck Surg 2023; 168 (03) 491-500
• 2 Lal D, Rounds AB, Divekar R. Gender-specific differences in chronic rhinosinusitis patients electing endoscopic sinus surgery. Int Forum Allergy Rhinol 2016; 6 (03) 278-286
• 3 Mendolia-Loffredo S, Laud PW, Sparapani R, Loehrl TA, Smith TL. Sex differences in outcomes of sinus surgery. Laryngoscope 2006; 116 (07) 1199-1203
• 4 Espersen J, Weber U, Römer-Franz A, Lenarz T, Stolle SRO, Warnecke A. Level of sex hormones and their association with acetylsalicylic acid intolerance and nasal polyposis. PLoS One 2020; 15 (12) e0243732
• 5 Bhenswala PN, Schlosser RJ, Nguyen SA, Munawar S, Rowan NR. Sinonasal quality-of-life outcomes after endoscopic endonasal skull base surgery. Int Forum Allergy Rhinol 2019; 9 (10) 1105-1118
• 6 Ramos L, Massey CJ, Asokan A, Rice JD, Kroehl M, Ramakrishnan VR. Examination of sex differences in a chronic rhinosinusitis surgical cohort. Otolaryngol Head Neck Surg 2022; 167 (03) 583-589
• 7 McCoul ED, Anand VK, Bedrosian JC, Schwartz TH. Endoscopic skull base surgery and its impact on sinonasal-related quality of life. Int Forum Allergy Rhinol 2012; 2 (02) 174-181
• 8 Choi KJ, Ackall FY, Truong T. et al. Sinonasal quality of life outcomes after extended endonasal approaches to the skull base. J Neurol Surg B Skull Base 2019; 80 (04) 416-423
• 9 Buchlak QD, Esmaili N, Bennett C, Wang YY, King J, Goldschlager T. Predictors of improvement in quality of life at 12-month follow-up in patients undergoing anterior endoscopic skull base surgery. PLoS One 2022; 17 (07) e0272147
• 10 Fleseriu CM, Beswick DM, Maoz SL. et al. Predictive factors for decreased baseline quality of life in patients with sinonasal malignancies. Int Forum Allergy Rhinol 2023; 14 (04) 775-785